Israel Englander’s Galectin Therapeutics Inc. - Warrants GALTW Stock Holding History

Israel Englander’s Portfolio GALTW Stock Details GALTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-640,800	Closed	-$35K	–	4144
2016 Q4	$35K	Hold	640,800	–	–	﹤0.01%	3267
2016 Q3	$101K	Buy	+640,800	New	+$226K	﹤0.01%	3133

Israel Englander's GALTW Position: Q1 2017 in Review

Israel Englander sold out of Galectin Therapeutics Inc. - Warrants (GALTW) in Q1 2017, closing a stake of 640,800 shares — an estimated $35K sold.

Israel Englander first reported a position in GALTW in Q3 2016 and held it in 2 quarters. The position peaked at $101K in Q3 2016. 0 funds tracked by Wall St. Rank hold GALTW as of Q1 2017.

Israel Englander reported no remaining Galectin Therapeutics Inc. - Warrants position as of Q1 2017 after selling out during the quarter.
Israel Englander sold 640,800 Galectin Therapeutics Inc. - Warrants shares in Q1 2017, an estimated $35K.
Israel Englander first reported a position in Galectin Therapeutics Inc. - Warrants in Q3 2016 and held it in 2 quarters.
Israel Englander's Galectin Therapeutics Inc. - Warrants position peaked at $101K in Q3 2016.
0 funds tracked by Wall St. Rank held Galectin Therapeutics Inc. - Warrants as of Q1 2017.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.